Bionomics Ltd ADR Insiders
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Bionomics employs about 8 people. The company is managed by 9 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 0.89 employees per reported executive. Break down of Bionomics' management performance can provide insight into the company performance.
Bionomics |
Bionomics Management Team Effectiveness
The company has return on total asset (ROA) of (0.3958) % which means that it has lost $0.3958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7844) %, meaning that it created substantial loss on money invested by shareholders. Bionomics' management efficiency ratios could be used to measure how well Bionomics manages its routine affairs as well as how well it operates its assets and liabilities.Bionomics Workforce Comparison
Bionomics Ltd ADR is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 543. Bionomics claims roughly 8.0 in number of employees contributing just under 2% to equities under Health Care industry.
Bionomics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bionomics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bionomics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bionomics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Papapetropoulos Spyros over two months ago Disposition of tradable shares by Papapetropoulos Spyros of Bionomics subject to Rule 16b-3 | ||
Wilson David Ian over three months ago Disposition of 100000 shares by Wilson David Ian of Bionomics at 0.2866 subject to Rule 16b-3 | ||
Wilson David Ian over six months ago Disposition of tradable shares by Wilson David Ian of Bionomics subject to Rule 16b-3 | ||
Papapetropoulos Spyros over six months ago Disposition of 1691688 shares by Papapetropoulos Spyros of Bionomics at 0.0321 subject to Rule 16b-3 |
Bionomics Notable Stakeholders
A Bionomics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bionomics often face trade-offs trying to please all of them. Bionomics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bionomics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Spyridon MD | President CEO | Profile | |
| Elizabeth Doolin | Senior Development | Profile | |
| DCPSA FFPM | Consultant Neuroscience | Profile | |
| Errol Souza | Ex Chairman | Profile | |
| FCA BEC | Financial Controller | Profile | |
| FCIS BCom | Company Secretary | Profile | |
| MD DFAPA | Acting Officer | Profile | |
| Julie Kerner | Senior Operations | Profile | |
| Connor MSc | VP Devel | Profile |
About Bionomics Management Performance
The success or failure of an entity such as Bionomics ADR often depends on how effective the management is. Bionomics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bionomics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bionomics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States.
Please note, the imprecision that can be found in Bionomics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bionomics Ltd ADR. Check Bionomics' Beneish M Score to see the likelihood of Bionomics' management manipulating its earnings.
Bionomics Workforce Analysis
Traditionally, organizations such as Bionomics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bionomics within its industry.Bionomics Manpower Efficiency
Return on Bionomics Manpower
| Revenue Per Employee | 2.5K | |
| Revenue Per Executive | 2.2K | |
| Net Loss Per Employee | 1.9M | |
| Net Loss Per Executive | 1.7M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |